Suppr超能文献

相似文献

1
Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS.
Curr Alzheimer Res. 2012 Nov;9(9):1050-8. doi: 10.2174/156720512803569046.
5
Measuring Alzheimer's disease progression with transition probabilities: estimates from CERAD.
Neurology. 2001 Sep 25;57(6):957-64. doi: 10.1212/wnl.57.6.957.
7
Measuring Alzheimer's disease progression with transition probabilities in the Taiwanese population.
Int J Geriatr Psychiatry. 2004 Mar;19(3):266-70. doi: 10.1002/gps.1076.
9
Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
Curr Alzheimer Res. 2018 Mar 14;15(5):474-481. doi: 10.2174/1567205014666171010112518.

引用本文的文献

2
Racial/ethnic differences in neuropsychiatric disturbances associated with incident dementia.
Alzheimers Dement (Amst). 2024 Jul 5;16(3):e12615. doi: 10.1002/dad2.12615. eCollection 2024 Jul-Sep.
3
Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?
Cost Eff Resour Alloc. 2023 Aug 9;21(1):51. doi: 10.1186/s12962-023-00463-7.
4
Cost-utility analysis of a multispecialty interprofessional team dementia care model in Ontario, Canada.
BMJ Open. 2023 Apr 19;13(4):e064882. doi: 10.1136/bmjopen-2022-064882.
5
Using dynamic microsimulation to project cognitive function in the elderly population.
PLoS One. 2022 Sep 15;17(9):e0274417. doi: 10.1371/journal.pone.0274417. eCollection 2022.
6
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US.
JAMA Neurol. 2022 May 1;79(5):478-487. doi: 10.1001/jamaneurol.2022.0315.
7
Cost-effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price.
Alzheimers Dement (N Y). 2022 Mar 7;8(1):e12256. doi: 10.1002/trc2.12256. eCollection 2022.
8
Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease.
Neurol Ther. 2021 Dec;10(2):919-940. doi: 10.1007/s40120-021-00273-0. Epub 2021 Aug 23.

本文引用的文献

2
Lethality of Alzheimer disease and its impact on nursing home placement.
Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):90-5. doi: 10.1097/WAD.0b013e31819fe7d1.
3
Stability of the Clinical Dementia Rating, 1979-2007.
Arch Neurol. 2009 Jun;66(6):773-7. doi: 10.1001/archneurol.2009.69.
4
Recent trends in Alzheimer disease mortality in the United States, 1999 to 2004.
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):165-70. doi: 10.1097/wad.0b013e3181902c3e.
5
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.
J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):600-7. doi: 10.1136/jnnp.2008.158964. Epub 2009 Feb 9.
6
Systematic review of the effect of education on survival in Alzheimer's disease.
Int Psychogeriatr. 2009 Feb;21(1):25-32. doi: 10.1017/S1041610208008053. Epub 2008 Nov 25.
8
Survival in Alzheimer disease: a multiethnic, population-based study of incident cases.
Neurology. 2008 Nov 4;71(19):1489-95. doi: 10.1212/01.wnl.0000334278.11022.42.
10
2008 Alzheimer's disease facts and figures.
Alzheimers Dement. 2008 Mar;4(2):110-33. doi: 10.1016/j.jalz.2008.02.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验